MNPR · Categories · Form 3

MNPR - SEC Form 3 initial insider statements

Monopar Therapeutics Inc. (MNPR) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for MNPR

• 58d
  SEC Form 3 filed by new insider Rodriguez Susan

  3 - Monopar Therapeutics (0001645469) (Issuer)
• 421d
  New insider Talukdar Lavina claimed ownership of 14,001 shares (SEC Form 3)

  3 - Monopar Therapeutics (0001645469) (Issuer)
• 422d
  SEC Form 3 filed by new insider Vu Quan Anh

  3 - Monopar Therapeutics (0001645469) (Issuer)
• 667d
  SEC Form 3 filed by new insider Radhakrishnan Karthik

  3 - Monopar Therapeutics (0001645469) (Issuer)
• 1754d
  SEC Form 3 filed by Filho Jose Octavio Pinto Costa

  3 - Monopar Therapeutics (0001645469) (Issuer)
• 1794d
  SEC Form 3 filed by Cittadine Andrew (Amendment)

  3/A - Monopar Therapeutics (0001645469) (Issuer)
• 1795d
  SEC Form 3 filed by Cittadine Andrew

  3 - Monopar Therapeutics (0001645469) (Issuer)

Other MNPR categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends